Press release
Cancer Vaccines Market Set to Surge to $7.3 Billion by 2027 at a 12.6% CAGR
Cancer Vaccines Market
Read More: https://www.alliedmarketresearch.com/cancer-vaccines-market
Cancer Vaccines Market Growth Factors
Several factors contribute to the growth of the cancer vaccines market:
- Increasing Cancer Incidences: The rising number of cancer cases globally is a significant driver for the demand for effective preventive and therapeutic vaccines.
- Advancements in Immunotherapy: Innovations in immunotherapy, including the development of personalized cancer vaccines, have enhanced treatment efficacy and expanded market opportunities.
- Government Initiatives and Funding: Increased investments and funding from governments and private sectors in cancer research and vaccine development are propelling market growth.
- Rising Awareness and Education: Public awareness campaigns and educational programs about cancer prevention and the benefits of vaccination are driving demand for cancer vaccines.
- Technological Advancements: Continuous research and development in vaccine technology, including the use of mRNA platforms, are leading to more effective and targeted cancer vaccines.
Get Sample PDF Copy Here: https://www.alliedmarketresearch.com/request-sample/1453
Cancer Vaccines Market Segmentation
The cancer vaccines market is categorized based on technology, type, indication, end user, and region.
By Technology:
- Recombinant Cancer Vaccines: These vaccines are the major revenue contributors, with a significant projected growth during the forecast period. The increase in adoption of recombinant technology and the rise in utilization of recombinant vaccines are key factors driving this segment.
- Dendritic Cells (DC) Cancer Vaccines: Utilize dendritic cells to present cancer antigens to the immune system, enhancing the body's response to cancer cells.
- Antigen/Adjuvant Cancer Vaccines: Combine specific antigens with adjuvants to boost the immune response against cancer cells.
- Viral Vector & DNA Cancer Vaccines: Employ viral vectors or DNA to deliver cancer-specific antigens into the body, stimulating an immune response.
By Type:
- Preventive Cancer Vaccines: Designed to prevent cancer in healthy individuals by stimulating immunity against cancer-causing agents.
- Therapeutic Cancer Vaccines: Aimed at treating existing cancers by enhancing the body's immune response to cancer cells.
By Indication:
- Cervical Cancer: The major shareholder in the global cancer vaccines market, driven by the high prevalence of cervical cancer and the increase in HPV infections.
- Prostate Cancer: Vaccines targeting prostate-specific antigens to stimulate an immune response against prostate cancer cells.
- Others: Includes vaccines targeting various other cancers such as melanoma, lung cancer, and breast cancer.
By End User:
- Pediatric: Cancer vaccines administered to children for prevention or treatment of cancer.
- Adult: Cancer vaccines administered to adults for prevention or treatment of cancer.
By Region:
- North America: Dominates the market due to advanced healthcare infrastructure and high adoption rates of cancer vaccines.
- Europe: Significant market share with increasing government initiatives in cancer research.
- Asia-Pacific: Exhibits the highest CAGR, driven by rising cancer incidences and improving healthcare facilities.
- LAMEA (Latin America, Middle East, and Africa): Emerging markets with growing awareness and healthcare investments.
Key Players in the Cancer Vaccines Market
The cancer vaccines market features several prominent players, including:
- Merck & Co., Inc.
- GlaxoSmithKline plc
- Bavarian Nordic
- Eli Lilly and Company
- Moderna, Inc.
- eTheRNA immunotherapies
- AstraZeneca plc
- Novartis International AG
- Sanofi S.A.
- Pfizer Inc.
The cancer vaccines market is poised for substantial growth, driven by increasing cancer incidences, advancements in immunotherapy, and supportive government initiatives. With ongoing research and development, the market is expected to expand, offering new opportunities for both existing and emerging players in the oncology sector.
Procure Complete Report Here: https://www.alliedmarketresearch.com/checkout-final/c7ab65485bd397bbdaf81fcfe598ad46?utm_source=Nilesh.Musale
Thanks for reading this article; you can also get an individual chapter-wise sections or region-wise report versions like North America, LATAM, Europe, or Southeast Asia.
Contact Us:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
About Us:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cancer Vaccines Market Set to Surge to $7.3 Billion by 2027 at a 12.6% CAGR here
News-ID: 3979237 • Views: …
More Releases from Allied Market Research
Tourism Event Market 2026 : to Cross $2.5 Trillion, Globally, by 2032 at 4.6% CA …
Allied Market Research published a report, titled, "Tourism Event Market by Type (Exhibition and Conference, Festival, Corporate Events, Music Concerts, Sports, Others), by Channel (Virtual Channel, Physical Channel), by Revenue Source (Online Registration, Offline Registration, Sponsorship, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032. According to the report, the global tourism event industry generated $1.6 trillion in 2022 and is anticipated to generate $2.5 trillion by 2032, witnessing a CAGR…
Athleisure Market 2026 : Expected to Surpass $3.2 Billion by 2032
According to a new report published by Allied Market Research, titled, "Athleisure Market," The Athleisure Market Size was valued at $2 billion in 2022, and is estimated to reach $3.2 billion by 2032, growing at a CAGR of 5.2% from 2023 to 2032. In 2023, the female segment occupied the largest market share as they are one of the most frequent purchasers and adorners of athleisure wear and apparel.
Clothing made…
Polycrystalline Diamond Market Predicted to Cross $1.6 Billion by 2032
Allied Market Research has recently published a report, titled, "Polycrystalline Diamond Market by Type (PCD Milling Tools, PCD Turning Tools, Others), by Application (Automotive, Machinery, Aerospace, Semiconductors, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032". According to the report, the global polycrystalline diamond market generated $900.6 million in 2022 and is anticipated to generate $1.6 billion by 2032, witnessing a CAGR of 6.1% from 2023 to 2032.
Sample Copy of…
Global Real Estate Market to Garner $4,923.3 Bn at 5.3% CAGR by 2031: Allied Mar …
Allied Market Research published a report, titled, "Real Estate Market By Property (Residential, Commercial, Industrial), By Business (Sales, Rental), By Type (Land, Buildings): Global Opportunity Analysis and Industry Forecast, 2021-2031." According to the report, the global real estate industry is estimated to generate $28,917.7 billion in 2021 and $4,923.3 billion by 2031, witnessing a CAGR of 5.3% from 2022 to 2031.
Download Sample Copy: https://www.alliedmarketresearch.com/request-sample/6394
Drivers, Restraints, and…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…
